Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Metaflow Ltd. | UNKNOWN |
Not provided
Not provided
Not provided
Not provided
Not provided
This randomized, interventional study examines the effects of short-term carbohydrate restriction, with and without caloric restriction, on indices of metabolic flexibility in healthy adults. Participants are randomly assigned to either a low-carbohydrate diet or a standard diet under energy balance, followed by the same diet under controlled caloric restriction. Primary outcomes include measures of carbon dioxide production, breath ketones and interstitial glucose. Secondary outcomes include blood and urinary ketones, body weight, body composition, and selected metabolic biomarkers.
This is a monocentric, randomized, open-label nutrition intervention conducted in healthy adults aged 18 to 40 years. The study investigates the effects of short-term carbohydrate and caloric restriction on indices of metabolic flexibility.
After screening and baseline assessments, participants undergo an initial period of energy balance with a standardized diet, followed by a 2-week intervention phase. Participants are randomly assigned in a 1:1 ratio to either a low-carbohydrate diet or a standard mixed diet. Participants are instructed to maintain their habitual physical activity throughout the study. During the first week of the intervention period, energy intake is equivalent to estimated energy requirements. During the second week, energy intake is reduced by ~500 kcal/d.
Metabolic outcomes are assessed using repeated laboratory and remote measurements. Primary outcomes include breath-based measures of carbon dioxide and acetone production, as well as continuous glucose monitoring. Secondary outcomes include urinary and capillary blood ketones, body weight, body composition, resting metabolic rate, plasma glucose and selected biomarkers (leptin, insulin, triiodothyronine, GLP-1, HbA1c).
Data are collected at baseline, during the intervention, and post-intervention. The total participation time per participant is approximately three weeks. The study aims to characterize short-term metabolic responses to dietary carbohydrate manipulation and energy deficit under controlled conditions.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Low-Carbohydrate Diet | Experimental | Participants assigned to this arm follow a low-carbohydrate diet. Daily carbohydrate intake is reduced to approximately 75-125 g per day (about 15% of total energy intake), with remaining energy derived primarily from fat (~70%) and protein (~15%). Diets are individually tailored to meet estimated energy and micronutrient requirements. Participants are instructed to maintain their habitual physical activity throughout the study. |
|
| Standard Diet | Active Comparator | Participants assigned to this arm follow a standard mixed diet combined. The diet consists of approximately 50-55% carbohydrates, 25-35% fat, and 15% protein. Diets are individually tailored to meet estimated energy and micronutrient requirements. Participants are instructed to maintain their habitual physical activity throughout the study. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Low-Carbohydrate Diet | Other | Participants receive a low-carbohydrate diet. All meals are provided and individually tailored based on estimated energy requirements. Carbohydrate intake is restricted to 75-125 g per day, with the remaining energy intake derived from fat and protein. The intervention is administered for 14 days. |
| Measure | Description | Time Frame |
|---|---|---|
| Carbon dioxide production and breath acetone concentration | Carbon dioxide production and breath acetone concentration are assessed using portable breath analysis devices during standardized daily measurements and timepoints. | Baseline, during the energy-deficit intervention period, and post-intervention (over approximately 3 weeks) |
| Interstitial glucose concentration assessed by continuous glucose monitoring | Continuous glucose monitoring is used to assess interstitial glucose concentration, including average glucose levels, glucose variability, and time in glycemic ranges. | Continuously assessed throughout the study period (approximately 3 weeks) |
| Measure | Description | Time Frame |
|---|---|---|
| Urinary ketone concentration | Urinary ketone concentration is assessed once daily using reagent test strips and self-reported by participants. | Daily during the study period (approximately 3 weeks) |
| Capillary blood ketone concentration |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Karsten Köhler, Prof. Dr. | Professorship for Exercise, Nutrition and Health, Technical University of Munich | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Technical University of Munich | München | Bavaria | 80809 | Germany |
Individual participant data will be shared upon reasonable request in accordance with the Technical University of Munich's data sharing policy and applicable data protection regulations
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D050528 | Diet, Carbohydrate-Restricted |
| D031204 | Caloric Restriction |
| ID | Term |
|---|---|
| D004035 | Diet Therapy |
| D044623 | Nutrition Therapy |
| D013812 | Therapeutics |
| D004032 | Diet |
| D009747 |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
|
| Standard Diet With Caloric Restriction | Other | Participants receive a standard mixed diet. All meals are provided and individually tailored based on estimated energy requirements. The macronutrient distribution consists of approximately 50-55% carbohydrates, 25-35% fat, and 15% protein. The intervention is administered for 14 days. |
|
Capillary blood ketone concentration is measured once daily in the fasting state using a handheld ketone meter.
| Daily during the study period (approximately 3 weeks) |
| Fasting capillary blood glucose concentration | Fasting blood glucose concentration is measured once daily using a capillary blood glucose meter. | Daily during the study period (approximately 3 weeks) |
| Body weight | Body weight is measured daily using a Bluetooth-enabled electronic scale. | Daily during the study period (approximately 3 weeks) |
| Fat Mass | Fat mass is assessed using bioelectrical impedance analysis and air displacement plethysmography. | Baseline (Day 1), mid-intervention (approximately Day 14), and post-intervention (approximately Day 21) |
| Fat-Free Mass | Fat-free mass is assessed using bioelectrical impedance analysis and air displacement plethysmography. | Baseline (Day 1), mid-intervention (approximately Day 14), and post-intervention (approximately Day 21) |
| Body Fat Percentage | Body fat percentage is assessed using bioelectrical impedance analysis and air displacement plethysmography. | Baseline (Day 1), mid-intervention (approximately Day 14), and post-intervention (approximately Day 21) |
| Resting metabolic rate | Resting metabolic rate is assessed by indirect calorimetry during laboratory visits. | Baseline (Day 1), mid-intervention (approximately Day 14), and post-intervention (approximately Day 21) |
| Plasma Leptin Concentration | Blood samples are collected to assess plasma leptin concentration. | Baseline (Day 1), mid-intervention (approximately Day 14), and post-intervention (approximately Day 21) |
| Plasma Insulin Concentration | Blood samples are collected to assess plasma insulin concentration. | Baseline (Day 1), mid-intervention (approximately Day 14), and post-intervention (approximately Day 21) |
| Plasma Triiodothyronine (T3) Concentration | Blood samples are collected to assess plasma triiodothyronine (T3) concentration. | Baseline (Day 1), mid-intervention (approximately Day 14), and post-intervention (approximately Day 21) |
| Plasma Glucagon-Like Peptide-1 (GLP-1) Concentration | Blood samples are collected to assess plasma glucagon-like peptide-1 (GLP-1) concentration. | Baseline (Day 1), mid-intervention (approximately Day 14), and post-intervention (approximately Day 21) |
| Nutritional Physiological Phenomena |
| D000066888 | Diet, Food, and Nutrition |
| D010829 | Physiological Phenomena |
| D002149 | Energy Intake |